Final Chapter of the HealthTech Report Launched

Following Chapter 4, which focused on how disruptive innovation is driving change across existing health ecosystems, the final chapter of the HealthTech Report discusses opportunities for accelerating change in healthcare.

This new chapter, the last of the series, highlights the need for Asia Pacific's developing economies to harness innovation. Such innovation would enable their healthcare systems to "leapfrog" through what would ordinarily take years of growth, to achieve a desired end point. Ideally, this end point will be a developed system that is on par with the healthcare systems of mature economies in the region. It also discusses the importance of harmonising the legal framework across the region, so as to take advantage of the disruptive innovation that has started to shape the healthcare industry.

The HealthTech Report has been developed by Baker & McKenzie in partnership with The Propell Group, a boutique venture investor and advisory firm focused on healthtech early-stage companies. The HealthTech Report is available for download on the App Store and Google Play, and as a PDF version here.

For more information about The HealthTech Report, please contact Principal Lim Ren Jun at +65 6434 2721.

Ministry of Health Issues Guidelines for the Conduct of Sterile Pharmaceutical Services in Healthcare Institutions

The Ministry of Health, together with the Pharmaceutical Standards Working Committee, has issued Guidelines for the Conduct of Sterile Pharmaceutical Services in Healthcare Institutions (Guidelines).

The Guidelines seek to foster "good compounding practices" in hospitals and healthcare institutions, an area which was previously not regulated. The Guidelines cover all areas in the compounding of sterile preparations, including personnel, facilities, transport and processes involved to produce a sterile medicinal product. Service providers should be aware of these Guidelines, as it applies to service level agreements entered into between healthcare institutions and contractors for any of the above works relating to sterile preparations of pharmaceutical products.